News

Filter

Current filters:

None

7790 to 7799 of 95953 results

FDA approves first Cushing’s syndrome drug, Corcept’s Korlym

20-02-2012

Shares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.90 in after-hours trading on…

Corcept TherapeuticsKorlymNorth AmericaNovartisPharmaceuticalRare diseasesRegulationSignifor

Setback for Gilead’s oral hep C drug candidate

20-02-2012

There was disappointment for US biotech firm Gilead Sciences (Nasdaq: GILD) last Friday, when the company…

Anti-viralsBiotechnologyGilead SciencesResearch

uniQure to acquire Amsterdam Molecular Therapeutics business

19-02-2012

Netherlands-based human gene based therapies developer Amsterdam Molecular Therapeutics (Euronext: AMT)…

Amsterdam MolecularBiotechnologyMergers & AcquisitionsuniQure

Pfizer and Hisun flesh-out plans for generics JV in China

19-02-2012

Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Vivo Ventures raises $375 million to invest in health care in USA and China

19-02-2012

Vivo Ventures, a health care investment firm with offices in Palo Alto, California, Shanghai, and Chengdu,…

Asia-PacificFinancialHealthcareNorth AmericaPharmaceutical

7790 to 7799 of 95953 results

Back to top